Jaguar Health Statistics Share Statistics Jaguar Health has 1.91M
shares outstanding. The number of shares has increased by -85.67%
in one year.
Shares Outstanding 1.91M Shares Change (YoY) -85.67% Shares Change (QoQ) 101.87% Owned by Institutions (%) 0.81% Shares Floating 1.52M Failed to Deliver (FTD) Shares 1,294 FTD / Avg. Volume 1.21%
Short Selling Information The latest short interest is 30.89K, so 1.42% of the outstanding
shares have been sold short.
Short Interest 30.89K Short % of Shares Out 1.42% Short % of Float 1.42% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.19 and the forward
PE ratio is -2.95.
Jaguar Health's PEG ratio is
0.
PE Ratio -0.19 Forward PE -2.95 PS Ratio 0.64 Forward PS 0.2 PB Ratio 0.76 P/FCF Ratio -0.25 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Jaguar Health.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.63,
with a Debt / Equity ratio of 3.74.
Current Ratio 1.63 Quick Ratio 1.11 Debt / Equity 3.74 Debt / EBITDA -1 Debt / FCF -1.23 Interest Coverage -133.47
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $238.55K Profits Per Employee $-785.55K Employee Count 49 Asset Turnover 0.22 Inventory Turnover 0.19
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -94.11% in the
last 52 weeks. The beta is 0.6, so Jaguar Health's
price volatility has been higher than the market average.
Beta 0.6 52-Week Price Change -94.11% 50-Day Moving Average 2.22 200-Day Moving Average 11.59 Relative Strength Index (RSI) 32.58 Average Volume (20 Days) 106,990
Income Statement In the last 12 months, Jaguar Health had revenue of 11.69M
and earned -38.49M
in profits. Earnings per share was -130.69.
Revenue 11.69M Gross Profit 9.73M Operating Income -30.83M Net Income -38.49M EBITDA -36.66M EBIT -39.02M Earnings Per Share (EPS) -130.69
Full Income Statement Balance Sheet The company has 8M in cash and 36.53M in
debt, giving a net cash position of -28.52M.
Cash & Cash Equivalents 8M Total Debt 36.53M Net Cash -28.52M Retained Earnings -346.48M Total Assets 48.27M Working Capital -1.31M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -29.38M
and capital expenditures -231K, giving a free cash flow of -29.61M.
Operating Cash Flow -29.38M Capital Expenditures -231K Free Cash Flow -29.61M FCF Per Share -100.55
Full Cash Flow Statement Margins Gross margin is 83.27%, with operating and profit margins of -263.76% and -329.3%.
Gross Margin 83.27% Operating Margin -263.76% Pretax Margin -335.79% Profit Margin -329.3% EBITDA Margin -313.65% EBIT Margin -263.76% FCF Margin -253.36%
Dividends & Yields JAGX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for JAGX is $60,
which is 3536.4% higher than the current price. The consensus rating is "Buy".
Price Target $60 Price Target Difference 3536.4% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 24, 2025. It was a
backward
split with a ratio of 1:25.
Last Split Date Mar 24, 2025 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -13.24 Piotroski F-Score 3
